Vital Farms (VITL) director adds 6,100 shares in open-market buy

Rhea-AI Filing Summary

Vital Farms, Inc. director Glenda J. Flanagan reported an open-market purchase of 6,100 shares of Common Stock at a weighted average price of $8.33 per share. Following this buy, she directly holds 37,498 shares. The shares were bought in multiple trades at prices ranging from $8.33 to $8.34.

Insider Trade Summary

Net Buyer: 6,100 shares ($50,813)

Net Buy 1 txn

Insider Flanagan Glenda J

Role null

Bought 6,100 shs ($51K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	6,100	$8.33	$51K

Holdings After Transaction: Common Stock — 37,498 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 6,100 shares Weighted average price: $8.33 per share Post-transaction holdings: 37,498 shares +1 more

4 metrics

Shares purchased 6,100 shares Open-market buy of Common Stock

Weighted average price $8.33 per share Price for 6,100-share purchase

Post-transaction holdings 37,498 shares Shares directly held after purchase

Trade price range $8.33–$8.34 per share Range of individual trade prices

Key Terms

open-market purchase, weighted average price, Common Stock, Form 4

4 terms

open-market purchase financial

"reported an open-market purchase of 6,100 shares of Common Stock"

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Common Stock financial

"open-market purchase of 6,100 shares of Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Form 4 regulatory

"disclosed in the Form 4 filing"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Flanagan Glenda J

(Last) (First) (Middle)

C/O VITAL FARMS, INC.

3601 SOUTH CONGRESS AVENUE, SUITE A100

(Street)

AUSTIN TEXAS 78704

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Vital Farms, Inc. [ VITL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		P		6,100	A	$8.33(1)	37,498	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.33 to $8.34 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

	/s/ Francis Cullo, Attorney-in-Fact	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Vital Farms (VITL) report in this Form 4?

Vital Farms reported that director Glenda J. Flanagan bought 6,100 shares of Common Stock in an open-market transaction at a weighted average price of $8.33 per share, increasing her directly held position to 37,498 shares.

At what price did Glenda J. Flanagan buy Vital Farms (VITL) shares?

Glenda J. Flanagan purchased Vital Farms Common Stock at a weighted average price of $8.33 per share, with individual trades executed in a narrow range between $8.33 and $8.34 per share during the reported transaction.

How many Vital Farms (VITL) shares does the director hold after this transaction?

After the reported open-market purchase, director Glenda J. Flanagan directly holds 37,498 shares of Vital Farms Common Stock. This figure reflects her position immediately following the acquisition of 6,100 additional shares disclosed in the Form 4 filing.

Was the Vital Farms (VITL) insider transaction a purchase or a sale?

The Form 4 shows an open-market purchase. Director Glenda J. Flanagan acquired 6,100 shares of Vital Farms Common Stock, categorized as a buy transaction, rather than a sale or disposition of shares in the market.

How is the Vital Farms (VITL) transaction price range described in the Form 4 footnote?

The transaction price is reported as a weighted average, with individual trades occurring between $8.33 and $8.34 per share. The footnote notes that detailed trade-by-trade pricing is available to the issuer, security holders, or SEC staff upon request.